Similar articles

• A dental complication involving Pseudomonas during chemotherapy for acute lymphoblastic leukemia.

  Cheatham BD, Henry RJ. Cheatham BD, et al. J Clin Pediatr Dent. 1994 Spring;18(3):215-7. J Clin Pediatr Dent. 1994. PMID: 8054308
• Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.

  Guillot E, Sermet I, Ferroni A, Chhun S, Pons G, Zahar JR, Jullien V. Guillot E, et al. Pharmacotherapy. 2010 Dec;30(12):1252-8. doi: 10.1592/phco.30.12.1252. Pharmacotherapy. 2010. PMID: 21114393
• Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.

  Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E; Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient. Cantón R, et al. Clin Microbiol Infect. 2005 Sep;11(9):690-703. doi: 10.1111/j.1469-0691.2005.01217.x. Clin Microbiol Infect. 2005. PMID: 16104983 Review.
• Tuberculosis and immune thrombocytopenia.

  Madkaikar M, Ghosh K, Jijina F, Gupta M, Rajpurkar M, Mohanty D. Madkaikar M, et al. Haematologica. 2002 Aug;87(8):ELT38. Haematologica. 2002. PMID: 12161383 No abstract available.
• [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].

  Kernen Y, Sauty A, Roulet M. Kernen Y, et al. Rev Med Suisse. 2005 Mar 2;1(9):637-8, 640. Rev Med Suisse. 2005. PMID: 15813341 Review. French.